Comprehensive biomarker analyses identifies HER2, EGFR, MET RNA expression and thymidylate synthase 5'UTR SNP as predictors of benefit from S-1 adjuvant chemotherapy in Japanese patients with stage II/III gastric cancer

Yoshikawa, T, Aoyama, T, Sakamaki, K et al. (19 more authors) (2019) Comprehensive biomarker analyses identifies HER2, EGFR, MET RNA expression and thymidylate synthase 5'UTR SNP as predictors of benefit from S-1 adjuvant chemotherapy in Japanese patients with stage II/III gastric cancer. Journal of Cancer, 10 (21). pp. 5130-5138. ISSN 1837-9664

Abstract

Metadata

Authors/Creators:
  • Yoshikawa, T
  • Aoyama, T
  • Sakamaki, K
  • Oshima, T
  • Lin, J
  • Zhang, S
  • Sapari, NS
  • Soong, R
  • Tan, I
  • Chan, XB
  • Bottomley, D
  • Hewitt, LC
  • Arai, T
  • Teh, BT
  • Epstein, D
  • Ogata, T
  • Kameda, Y
  • Miyagi, Y
  • Tsuburaya, A
  • Morita, S
  • Grabsch, HI https://orcid.org/0000-0001-9520-6228
  • Tan, P
Copyright, Publisher and Additional Information: © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/).
Dates:
  • Published: 28 August 2019
  • Accepted: 25 June 2019
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 13 Jan 2020 14:19
Last Modified: 13 Jan 2020 14:19
Status: Published
Publisher: Ivyspring International Publisher
Identification Number: https://doi.org/10.7150/jca.34741
Related URLs:

Share / Export

Statistics